The <i>FGFR3</i> Mutation is Related to Favorable pT1 Bladder CancerBas W.G. van Rhijn, Bharati Bapat, Neil Fleshner et al.|The Journal of Urology|2011Cited by 102
Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W.G. van Rhijn, Alexandre R. Zlotta, Peter J. Boström et al.|British Journal of Urology|2012Cited by 64
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classificationsBas W.G. van Rhijn, Theodorus van der Kwast, Alexandre R. Zlotta et al.|Modern Pathology|2014Cited by 47
THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCERBas W. van Rhijn, Alexandre R. Zlotta, Chris H. Bangma et al.|The Journal of Urology|2009Cited by 8